ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-35246

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core).

Published Apr 21, 2026 · catalog updated Jun 17, 2026 · vm virtualbox

Check if you run it

No confirmed exploitation is on record for CVE-2026-35246. EPSS is 0.15%. Act only if a listed version of vm virtualbox is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.5
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.15%
Remediation
Advisory link
Affected products
cpe oracle/vm virtualbox

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). The supported version that is affected is 7.2.6. Difficult to exploit vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 7.5 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:H/PR:H/UI:N/S:C/C:H/I:H/A:H).

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe oracle/vm virtualbox7.2.6

How to fix CVE-2026-35246

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-35246. EPSS is 0.15%. Act only if a listed version of vm virtualbox is installed.

Which versions are affected?

Compare what you have installed with oracle/vm virtualbox 7.2.6. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-284: Improper Access Control. EPSS 0.15%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Apr 21, 2026 · NIST NVD

    Detected

    Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). The supported version that is affected is 7.2.6. Difficult to exploit vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact

  2. Jun 17, 2026 · NIST NVD

    Updated

    Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). The supported version that is affected is 7.2.6. Difficult to exploit vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact

Sources

  • CVE.orgVulnerability recordCVE-2026-35246

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-35246

    30-day exploitation probability 0.1%

    first.org
  • NIST NVDVulnerability recordCVE-2026-35246

    Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). The supported version that is affected is 7.2.6. Difficult to exploit vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.